Immunotherapy Combo Treats Advanced Kidney Cancer
FRIDAY, Oct. 2, 2020 -- Nivolumab combined with cabozantinib is superior to sunitinib alone for the treatment of advanced clear cell renal cell carcinoma, according to a study presented at the annual meeting of the European Society for Medical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Kidney Cancer | Pharmaceuticals | Renal Cell Carcinoma | Study | Urology & Nephrology